Medical Xpress on MSN11 天
Clinical trial finds RNA inhibitor effectively reduces 'bad cholesterol' in patients with ...The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...
Omega-3 fatty acids have been linked to many health benefits. In particular, they may help promote brain and heart health, reduce inflammation, and protect against several chronic conditions ...
Anglia Ruskin University and Arctic Bioscience are researching herring roe omega-3 to uncover its benefits for exercise ...
The hallmarks of cancer include dysregulated metabolism and immune evasion. As a basic way of metabolism, lipid metabolism is reprogrammed for the rapid energy and nutrient supply in the occurrence ...
10 天
News Medical on MSNOlpasiran significantly lowers "bad cholesterol" linked to cardiovascular riskThe RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...
From fatty acids, the most fundamental biological lipid, glycerolipids, phospholipids, and sphingolipids, to lipoproteins and steroid molecules such as cholesterol, oxysterols, vitamin D, lipids all ...
A phase 2 trial shows that olpasiran, an RNA-based therapy, reduces lipoprotein(a) [Lp(a)] levels by more than 95% in ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果